Treffer: Impact of the Cancer Risk Intake System on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy

Title:
Impact of the Cancer Risk Intake System on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy
Source:
Journal of general internal medicine. 20(4):360-365
Publisher Information:
Heidelberg: Springer, 2005.
Publication Year:
2005
Physical Description:
print, 46 ref
Original Material:
INIST-CNRS
Document Type:
Fachzeitschrift Article
File Description:
text
Language:
English
Author Affiliations:
Duke University Medical Center, Durham, NC, United States
Indiana University School of Nursing, Indianapolis, IN, United States
Durham Veterans Affairs Medical Center, Durham, NC, United States
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, United States
ISSN:
0884-8734
Rights:
Copyright 2005 INIST-CNRS
CC BY 4.0
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Notes:
Scanning and diagnostic techniques (generalities)
Accession Number:
edscal.16834229
Database:
PASCAL Archive

Weitere Informationen

The Cancer Risk Intake System (CRIS). a computerized program that matches objective cancer risks to appropriate risk management recommendations, was designed to facilitate patient-clinician discussion. We evaluated CRIS in primary care settings via a single-group, self-report, pretest-posttest design. Participants completed baseline telephone surveys, used CRIS during clinic visits, and completed follow-up surveys 1 to 2 months postvisit. Compared with proportions reporting having had discussions at baseline, significantly greater proportions of participants reported having discussed tamoxifen, genetic counseling, and colonoscopy, as appropriate, after using CRIS. Most (79%) reported CRIS had caused their discussion. CRIS is an easily used, disseminable program that showed promising results in primary care settings.